Ginsenoside aPPD could be an effective treatment for triple-negative breast cancer
Triple-negative breast cancer is an aggressive type of breast cancer, accounting for 12-24% of all breast cancers. Characterized by a lack of estrogen receptor (ER)-, progesterone receptor (PR)-, and HER2-, Triple-negative breast cancer is...